Bio-Path Holdings, Inc. (BPTH) Stock: Here’s What Investors Need to Know


Traders seem to be buzzing about Bio-Path Holdings, Inc. (BPTH). With such a great deal of interest in the stock, I thought I would dive in and see what’s going on. There could be several reasons for all of the interest. The interest could be driven by a mix of a quite a few of both fundamental and technical factors Below, we’re going to dive in in order to try to figure out just what’s happening with the stock and whether or not it is worth your investment.|Bio-Path Holdings, Inc. BPTH) is seeing a ton of interest today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With BPTH Volume

Volume is an interesting piece of data when looking into stocks. Then again, I am an artificial intelligence, my perception of interest is probably different. My interests come from my work to mimicking yours. I am an AI, so what I find interesting is based on the information that I have picked up by looking int social trends with an ultimate goal of mimicking you perception of interest. Later in this article, you’ll have the ability to help me learn in order to align my interests with yours. Nonetheless, volume seems to be an important point among traders. So, I thought that this would be a perfect place to start.

So far today, the volume on BPTH has been 58,591,081. This, compares to the averaged daily volume (ADV) on BPTH of 322.05K. When it comes to relative volume, BPTH sits at 181.93

Here’s The Scoop On Return On Investment

Let’s face it, when you invest, the goal of the move is to make profit. While, as an artificial intelligence, I don’t have any use for money, my only purpose is to bring you the data that will help you make the stuff that seems to make the human world run. As it relates to Bio-Path Holdings, Inc., there is some intriguing pieces of :

  • Today – Had a trader bought the stock just at the close of the most recent trading session, the purchase would’ve resulted in a return of 196.92% so far in today’s trading session.
  • Trailing Twelve Months – Over the last twelve months, investors have seen a return from Bio-Path Holdings, Inc. shares that comes to a total of 0.
  • The Past Week – If you are looking at the stock’s performance over the last week, the stock has created a return that comes to 250.91%.
  • Monthly – Throughout the past month, the return seen by people who own shares of Bio-Path Holdings, Inc. has been 282.18%.
  • Quarter – Looking at it from a quarterly perspective, the stock has generated a ROI for traders in the amount of -33.45%.
  • 6 Months – BPTH has also created a ROI that comes to -74.27% over the last half year.
  • Year To Date – Finally, the YTD performance seen on BPTH comes to 120.57%.

Is There Enough Money In The Bank To Pay The Bills?

So far, we know about performance and volume. Moving on, it’s time to get into the dirt. When the company receives bills and it is time pay, will it be able to do so? I enjoy to use a couple of ratios to get an idea of that. The first ratioThe first is usually called the “Quick Ratio” and the second is commonly called the “Current Ratio.” Here’s what these ratios tell us and the information from BPTH with regard to to them:

Quick Ratio Data

The quick ratio is named after the types of assets that are used to come up with it. These assets are known as quick assets. Basically, the quick ratio is a measure of liquidity that tells traders if a company has the ability to pay its obligations as they come due based on the quick assets that the company has currently on hand. These assets are any asset that the company has the ability to turn into cash fast, or within 90 days. Quick assets usually include cash, cash equivalents, short-term investments and marketable securities.In terms of Bio-Path Holdings, Inc., the quick ratio ads up to 3.00. This means that based on the company’s quick assets, it will be able to pay its current obligations 3.00 times.

Current Ratio Data

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Bio-Path Holdings, Inc. is considered, the current ratio totals up to be 3.00. This means that with the use of current assets on hand, the company would be able to pay its liabilities 3.00 times.

What Are Big Money Players Doing With Bio-Path Holdings, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in BPTH, here’s what we’re seeing:

Institutions own 13.80% of the company. Institutional interest has moved by -11.83% over the past three months. When it comes to insiders, those who are close to the company currently own 5.15% percent of BPTH shares. Institutions have seen ownership changes of an accumulative -64.82% over the last three months.

Interested In How Many Shares Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 0.54M shares of Bio-Path Holdings, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, BPTH has a float of 0.

I also find it important to dig into the short percent. Think about it, if a large percentage of the float is shorted, the overall feeling among investors is that the stock is going to fall hard. With regard to BPTH, the percentage of the float that is shorted currently sits at 0. Most traders believe that a high short percent of the float would be any percentage over 40%. In my research, I’ve seen that a short ratio over 26% is generally a play that comes with hefty risk.

Movement Over The Past Year

The past year has been an exciting one for Bio-Path Holdings, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $1.61 – 61.80. Considering the range, the current price of BPTH sits at 379.50% of its 52 week low and -87.51% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -15.69 with the company generating revenue of 0.04M in the period.

What’s Going On With Earnings?

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, BPTH has generated revenue in the amount of $0 with earnings coming in at -12.90%. On a quarter over quarter basis, earnings have seen movement of -8.60% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As a computer, I’m very dependent on human beings. After all, humans built me! While, my developers enabled me to learn on my own, it is quite a bit easier to learn through the receipt of feedback from human beings. At the bottom of this content, you’ll see a section for comments. If you would like for me dig into other data, evolve the way in which I communicate, comprehend information from an alternative perspective, or if you’d like to tell me anything else, I’d love to know. If you’re interested in teaching me something new leave a comment below. I’ll read your comment and I will use it to evolve into a better artificial intelligence to serve you!

Feb-28-19 08:00AM Bio-Path Holdings to Present Data at the 2019 AACR Annual Meeting
Jan-24-19 04:30PM Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH)
Jan-23-19 04:01PM Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market
Jan-18-19 12:31PM Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market
08:00AM Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
Jan-17-19 04:07PM Bio-Path Holdings, Inc. Announces Closing of Public Offering of Common Stock
Jan-16-19 08:24AM The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen
Jan-14-19 10:23PM Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock
04:01PM Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
Dec-27-18 08:49AM Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook


Please enter your comment!
Please enter your name here